Seizure susceptibility after manipulation of brain serotonin.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D004336:Drug Antagonism; D010134:Fenclonine / Q000008:administration & dosage / Q000494:pharmacology; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010433:Pentylenetetrazole / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D010634:Phenobarbital / Q000008:administration & dosage; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control*; D012701:Serotonin / Q000378:metabolism*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D012701:Serotonin; D006916:5-Hydroxytryptophan; D010134:Fenclonine; D010433:Pentylenetetrazole; D010634:Phenobarbital